| MLEC | Moolec Science SA | 0.01 | -100.00% |
| LSB | LakeShore Biopharma Co Ltd | 0.02 | -99.99% |
| ENVB | Enveric Biosciences Inc | 0.08 | -99.98% |
| CASI | CASI Pharmaceuticals Inc | 0.12 | -99.97% |
| KPRX | Kiora Pharmaceuticals Inc | 0.14 | -99.97% |
| JAGX | Jaguar Health Inc | 0.30 | -99.93% |
| LITS | Lite Strategy Inc | 0.31 | -99.93% |
| AFMD | Affimed N.V. | 0.53 | -99.88% |
| HRTX | Heron Therapeutics Inc | 0.54 | -99.88% |
| BDRX | Biodexa Pharmaceuticals Plc | 0.58 | -99.87% |
| ENSC | Ensysce Biosciences Inc | 0.61 | -99.86% |
| FTRE | Fortrea Holdings Inc | 0.63 | -99.86% |
| CLSD | Clearside Biomedical, Inc. Common Stock | 0.64 | -99.86% |
| ONCT | Oncternal Therapeutics Inc | 0.72 | -99.84% |
| CELU | Celularity Inc - Class A | 0.85 | -99.81% |
| SRPT | Sarepta Therapeutics Inc | 0.87 | -99.81% |
| SCNI | Scinai Immunotherapeutics Ltd | 0.97 | -99.78% |
| GOSS | Gossamer Bio Inc | 0.98 | -99.78% |
| QLGN | Qualigen Therapeutics, Inc. Common Stock | 1.12 | -99.75% |
| XLO | Xilio Therapeutics Inc | 1.14 | -99.75% |
| PTN | Palatin Technologies Inc | 1.22 | -99.73% |
| BOLT | Bolt Biotherapeutics Inc | 1.25 | -99.72% |
| FBIOP | Fortress Biotech Inc | 1.25 | -99.72% |
| HCWB | HCW Biologics Inc | 1.25 | -99.72% |
| CRIS | Curis Inc | 1.30 | -99.71% |
| IMRN | Immuron Ltd | 1.34 | -99.70% |
| CSBR | Champions Oncology Inc | 1.36 | -99.70% |
| ADAP | Adaptimmune Therapeutics plc American Depositary Shares | 1.39 | -99.69% |
| RVNC | Revance Therapeutics Inc | 1.48 | -99.67% |
| KPTI | Karyopharm Therapeutics Inc | 1.50 | -99.66% |
| AVIR | Atea Pharmaceuticals Inc | 1.55 | -99.65% |
| MDXG | Mimedx Group Inc | 1.61 | -99.64% |
| SPRO | Spero Therapeutics Inc | 1.61 | -99.64% |
| VNDA | Vanda Pharmaceuticals Inc | 1.61 | -99.64% |
| CRMD | CorMedix Inc | 1.62 | -99.64% |
| NEUP | Neuphoria Therapeutics Inc | 1.70 | -99.62% |
| AGEN | Agenus Inc | 1.71 | -99.62% |
| MGNX | Macrogenics Inc | 1.74 | -99.61% |
| GLPG | Galapagos NV | 1.74 | -99.61% |
| SVA | Sinovac Biotech Ltd | 1.83 | -99.59% |
| PBYI | Puma Biotechnology Inc | 1.85 | -99.58% |
| NERV | Minerva Neurosciences Inc | 1.87 | -99.58% |
| FBIO | Fortress Biotech Inc | 1.87 | -99.58% |
| THTX | Theratechnologies Inc | 1.98 | -99.56% |
| BDTX | Black Diamond Therapeutics Inc | 2.11 | -99.53% |
| NAGE | Niagen Bioscience Inc | 2.12 | -99.53% |
| XBIO | Xenetic Biosciences Inc | 2.15 | -99.52% |
| RADX | Radiopharm Theranostics Ltd | 2.22 | -99.50% |
| MGX | Metagenomi Inc | 2.23 | -99.50% |
| HRMY | Harmony Biosciences Holdings Inc | 2.25 | -99.50% |
| NVAX | Novavax Inc | 2.32 | -99.48% |
| SPRC | SciSparc Ltd | 2.33 | -99.48% |
| GNFT | GENFIT S.A. American Depositary Shares | 2.44 | -99.45% |
| PLX | Protalix BioTherapeutics Inc | 2.44 | -99.45% |
| HYFT | MindWalk Holdings Corp | 2.48 | -99.45% |
| CDXS | Codexis Inc | 2.48 | -99.45% |
| SAVA | Cassava Sciences Inc. | 2.54 | -99.43% |
| RIGL | Rigel Pharmaceuticals | 2.54 | -99.43% |
| PHAR | Pharming Group N.V. | 2.55 | -99.43% |
| CTXR | Citius Pharmaceuticals Inc | 2.60 | -99.42% |
| VRCA | Verrica Pharmaceuticals Inc | 2.62 | -99.41% |
| FULC | Fulcrum Therapeutics Inc | 2.66 | -99.41% |
| APVO | Aptevo Therapeutics Inc | 2.70 | -99.39% |
| REVB | Revelation Biosciences Inc | 2.88 | -99.36% |
| SABS | SAB Biotherapeutics Inc | 2.96 | -99.34% |
| ARDX | Ardelyx Inc | 2.98 | -99.33% |
| CGEN | Compugen Ltd | 2.99 | -99.33% |
| VERU | Veru Inc | 3.11 | -99.30% |
| ATRA | Atara Biotherapeutics Inc | 3.13 | -99.30% |
| SXTP | 60 Degrees Pharmaceuticals Inc | 3.13 | -99.30% |
| EVGN | Evogene Ltd | 3.17 | -99.29% |
| ICCC | Immucell Corp | 3.24 | -99.27% |
| BGMS | Bio Green Med Solution Inc | 3.28 | -99.27% |
| AAPG | Ascentage Pharma Group International | 3.28 | -99.27% |
| MNKD | Mannkind Corp | 3.32 | -99.26% |
| VALN | Valneva SE | 3.35 | -99.25% |
| ARCT | Arcturus Therapeutics Holdings Inc | 3.36 | -99.25% |
| JAZZ | Jazz Pharmaceuticals plc | 3.37 | -99.25% |
| EVAX | Evaxion Biotech A/S | 3.38 | -99.24% |
| PTHS | Channel Therapeutics Corporation | 3.41 | -99.24% |
| BMRN | Biomarin Pharmaceutical Inc | 3.50 | -99.22% |
| BCAB | BioAtla Inc | 3.54 | -99.21% |
| SLDB | Solid Biosciences Inc | 3.65 | -99.18% |
| CUE | Cue Biopharma Inc | 3.66 | -99.18% |
| IPSC | Century Therapeutics Inc | 3.72 | -99.17% |
| BRNS | Barinthus Biotherapeutics Plc. | 3.80 | -99.15% |
| DNA | Ginkgo Bioworks Holdings Inc - Class A | 3.81 | -99.15% |
| INVA | Innoviva Inc | 3.81 | -99.15% |
| CLLS | Cellectis | 3.85 | -99.14% |
| LEGN | Legend Biotech Corp | 3.91 | -99.12% |
| ONCO | Onconetix Inc | 3.92 | -99.12% |
| ACAD | Acadia Pharmaceuticals Inc | 3.98 | -99.11% |
| ADMA | Adma Biologics Inc | 4.03 | -99.10% |
| IMCR | Immunocore Holdings plc | 4.27 | -99.04% |
| INCY | Incyte Corp | 4.28 | -99.04% |
| PHAT | Phathom Pharmaceuticals Inc | 4.30 | -99.04% |
| IVVD | Invivyd Inc | 4.31 | -99.04% |
| STRO | Sutro Biopharma Inc | 4.33 | -99.03% |
| GERN | Geron Corp | 4.51 | -98.99% |
| YMAB | Y-Mabs Therapeutics Inc | 4.57 | -98.98% |
| GMAB | Genmab | 4.58 | -98.98% |
| BCYC | Bicycle Therapeutics Plc | 4.64 | -98.96% |
| TARS | Tarsus Pharmaceuticals Inc | 4.69 | -98.95% |
| RARE | Ultragenyx Pharmaceutical Inc | 4.71 | -98.95% |
| ABUS | Arbutus Biopharma Corp | 4.76 | -98.94% |
| TLX | Telix Pharmaceuticals Ltd | 4.76 | -98.94% |
| APLM | Apollomics Inc - Class A | 4.77 | -98.93% |
| REGN | Regeneron Pharmaceuticals Inc | 4.77 | -98.93% |
| CHRS | Coherus Biosciences Inc | 4.77 | -98.93% |
| TRAW | Traws Pharma Inc | 4.77 | -98.93% |
| QTTB | Q32 Bio Inc | 4.95 | -98.89% |
| ZLAB | Zai Lab Ltd | 4.96 | -98.89% |
| DTIL | Precision Biosciences Inc | 5.04 | -98.87% |
| ACHV | Achieve Life Sciences Inc | 5.09 | -98.86% |
| VYGR | Voyager Therapeutics Inc | 5.23 | -98.83% |
| ELAB | PMGC Holdings Inc | 5.26 | -98.82% |
| PSTV | Plus Therapeutics Inc | 5.42 | -98.79% |
| CAI | Caris Life Sciences Inc - Class A | 5.44 | -98.78% |
| ENTA | Enanta Pharmaceuticals Inc | 5.51 | -98.77% |
| OSRH | Bellevue Life Sciences Acquisition Corp | 5.61 | -98.74% |
| ONC | BeiGene Ltd | 5.63 | -98.74% |
| RNA | Atrium Therapeutics Inc | 5.70 | -98.72% |
| EXEL | Exelixis Inc | 5.89 | -98.68% |
| HALO | Halozyme Therapeutics Inc | 5.90 | -98.68% |
| ARVN | Arvinas Inc | 5.98 | -98.66% |
| MRVI | Maravai LifeSciences Holdings Inc - Class A | 6.02 | -98.65% |
| GYRE | Gyre Therapeutics Inc | 6.04 | -98.65% |
| SCPH | scPharmaceuticals Inc | 6.10 | -98.64% |
| IOVA | Iovance Biotherapeutics Inc | 6.14 | -98.63% |
| ZVRA | Zevra Therapeutics Inc | 6.26 | -98.60% |
| CPRX | Catalyst Pharmaceuticals Inc | 6.46 | -98.55% |
| KROS | Keros Therapeutics Inc | 6.58 | -98.53% |
| MRKR | Marker Therapeutics Inc | 6.63 | -98.52% |
| OBIO | Orchestra BioMed Holdings Inc | 6.68 | -98.50% |
| AUPH | Aurinia Pharmaceuticals Inc | 6.89 | -98.46% |
| ANAB | AnaptysBio Inc | 6.90 | -98.46% |
| FDMT | 4D Molecular Therapeutics Inc | 6.92 | -98.45% |
| ZNTL | Zentalis Pharmaceuticals Inc | 7.13 | -98.40% |
| TCRX | Tscan Therapeutics Inc | 7.14 | -98.40% |
| RGNX | Regenxbio Inc | 7.23 | -98.38% |
| LENZ | LENZ Therapeutics Inc | 7.45 | -98.33% |
| ASMB | Assembly Biosciences Inc | 7.46 | -98.33% |
| SPRY | ARS Pharmaceuticals Inc | 7.57 | -98.31% |
| XTLB | X.T.L. Biopharmaceuticals Ltd | 7.58 | -98.30% |
| ALGS | Aligos Therapeutics Inc | 7.59 | -98.30% |
| FENC | Fennec Pharmaceuticals Inc | 7.60 | -98.30% |
| PRTA | Prothena Corporation plc | 7.62 | -98.29% |
| NTBL | Notable Labs Inc Ord | 7.65 | -98.29% |
| SEER | Seer Inc - Class A | 7.83 | -98.25% |
| PTCT | PTC Therapeutics Inc | 7.83 | -98.25% |
| VTGN | VistaGen Therapeutics Inc | 7.96 | -98.22% |
| TBPH | Theravance Biopharma Inc | 7.99 | -98.21% |
| CYCN | Cyclerion Therapeutics Inc | 8.06 | -98.20% |
| VCEL | Vericel Corp | 8.06 | -98.20% |
| ARTV | Artiva Biotherapeutics Inc | 8.11 | -98.18% |
| IMMP | Immutep Ltd | 8.12 | -98.18% |
| BNTX | BioNTech SE | 8.29 | -98.14% |
| ARQT | Arcutis Biotherapeutics Inc | 8.36 | -98.13% |
| IONS | Ionis Pharmaceuticals Inc | 8.58 | -98.08% |
| ALEC | Alector Inc | 9.04 | -97.98% |
| GOVX | Geovax Labs Inc | 9.09 | -97.97% |
| TECH | Bio-Techne Corp | 9.17 | -97.95% |
| LPCN | Lipocine Inc | 9.51 | -97.87% |
| NXTC | Nextcure Inc | 9.52 | -97.87% |
| BLRX | Bioline Rx Ltd | 9.56 | -97.86% |
| ACET | Adicet Bio Inc | 9.72 | -97.82% |
| SNGX | Soligenix Inc | 9.78 | -97.81% |
| TVTX | Travere Therapeutics Inc | 9.84 | -97.80% |
| SNDX | Syndax Pharmaceuticals Inc | 9.85 | -97.80% |
| VSTM | Verastem Inc | 9.87 | -97.79% |
| VRTX | Vertex Pharmaceuticals Inc | 9.89 | -97.79% |
| TNXP | Tonix Pharmaceuticals Holding Corp | 10.04 | -97.75% |
| HOWL | Werewolf Therapeutics Inc | 10.21 | -97.71% |
| IKT | Inhibikase Therapeutics Inc | 10.39 | -97.67% |
| OABI | OmniAb Inc | 10.42 | -97.67% |
| PYXS | Pyxis Oncology Inc | 10.69 | -97.61% |
| MDGL | Madrigal Pharmaceuticals Inc | 10.93 | -97.55% |
| CTNM | Contineum Therapeutics Inc - Class A | 11.15 | -97.50% |
| ARGX | Argen X SE | 11.27 | -97.48% |
| FHTX | Foghorn Therapeutics Inc | 11.34 | -97.46% |
| XNCR | Xencor Inc | 11.41 | -97.45% |
| DYAI | Dyadic International Inc DE | 11.58 | -97.41% |
| PALI | Palisade Bio Inc | 11.78 | -97.36% |
| CCCC | C4 Therapeutics Inc | 11.93 | -97.33% |
| TGTX | TG Therapeutics Inc | 12.00 | -97.31% |
| MRNA | Moderna Inc | 12.18 | -97.27% |
| XBIT | XBiotech Inc | 12.23 | -97.26% |
| CORT | Corcept Therapeutics Inc | 12.63 | -97.17% |
| MDWD | MediWound Ltd | 12.65 | -97.17% |
| ICU | SeaStar Medical Holding Corp | 12.86 | -97.12% |
| MIRM | Mirum Pharmaceuticals Inc | 12.95 | -97.10% |
| SRRK | Scholar Rock Holding Corp | 13.14 | -97.06% |
| RPRX | Royalty Pharma plc - Class A | 13.14 | -97.06% |
| URGN | UroGen Pharma Ltd | 13.37 | -97.01% |
| LXRX | Lexicon Pharmaceuticals Inc | 13.52 | -96.97% |
| ANL | Adlai Nortye Ltd | 13.52 | -96.97% |
| ATHE | Alterity Therapeutics Ltd | 13.60 | -96.96% |
| XCUR | Exicure Inc | 13.61 | -96.95% |
| CRVO | CervoMed Inc | 13.61 | -96.95% |
| SLGL | Sol-Gel Technologies Ltd | 13.67 | -96.94% |
| EDIT | Editas Medicine Inc | 13.68 | -96.94% |
| KURA | Kura Oncology Inc | 13.93 | -96.88% |
| GDTC | CytoMed Therapeutics Ltd | 14.02 | -96.86% |
| COYA | Coya Therapeutics Inc | 14.30 | -96.80% |
| NUVB | Nuvation Bio Inc - Class A | 14.36 | -96.79% |
| MGTX | MeiraGTx Holdings plc | 14.58 | -96.74% |
| XOMA | XOMA Royalty Corp | 14.63 | -96.73% |
| CVAC | CureVac N.V. | 14.83 | -96.68% |
| APLT | Applied Therapeutics Inc | 14.86 | -96.67% |
| RCUS | Arcus Biosciences Inc | 14.93 | -96.66% |
| CRBU | Caribou Biosciences Inc | 15.32 | -96.57% |
| IDYA | Ideaya Biosciences Inc | 15.70 | -96.49% |
| ARWR | Arrowhead Pharmaceuticals Inc | 16.28 | -96.36% |
| WVE | Wave Life Sciences Ltd | 16.43 | -96.32% |
| CLGN | CollPlant Biotechnologies Ltd New | 16.50 | -96.31% |
| LGVN | Longeveron Inc - Class A | 16.51 | -96.31% |
| ACOG | Alpha Cognition Inc | 16.80 | -96.24% |
| AXSM | Axsome Therapeutics Inc | 17.09 | -96.18% |
| PLUR | Pluri Inc | 17.50 | -96.08% |
| CANF | Can-Fite Biopharma Ltd | 17.56 | -96.07% |
| BEAM | Beam Therapeutics Inc | 17.79 | -96.02% |
| PRQR | ProQR Therapeutics N.V | 17.90 | -95.99% |
| IMNN | Imunon Inc | 17.94 | -95.98% |
| IPHA | Innate Pharma | 18.77 | -95.80% |
| ASND | Ascendis Pharma A/S | 20.12 | -95.50% |
| NRXS | Neuraxis Inc | 20.19 | -95.48% |
| EQ | Equillium Inc | 20.22 | -95.47% |
| LCTX | Lineage Cell Therapeutics Inc | 20.58 | -95.39% |
| VIVS | VivoSim Labs Inc | 20.99 | -95.30% |
| NTRB | Nutriband Inc | 21.11 | -95.28% |
| SEPN | Septerna Inc | 21.25 | -95.24% |
| PRLD | Prelude Therapeutics Inc | 21.25 | -95.24% |
| LGND | Ligand Pharmaceuticals Inc - Class B | 21.98 | -95.08% |
| ZYME | Zymeworks BC Inc | 22.33 | -95.00% |
| CTMX | CytomX Therapeutics Inc | 22.42 | -94.98% |
| APM | Aptorum Group Limited Class A Ordinary Shares | 23.35 | -94.77% |
| UNCY | Unicycive Therapeutics Inc | 23.75 | -94.68% |
| KALA | Kala Bio Inc | 23.75 | -94.68% |
| IRD | Ocuphire Pharma Inc | 23.98 | -94.63% |
| IGC | IGC Pharma Inc | 24.19 | -94.59% |
| VIR | Vir Biotechnology Inc | 24.75 | -94.46% |
| BRTX | BioRestorative Therapies Inc | 24.97 | -94.41% |
| NBP | NovaBridge Biosciences. | 25.39 | -94.32% |
| KRYS | Krystal Biotech Inc | 25.84 | -94.22% |
| CGEM | Cullinan Oncology Inc | 25.86 | -94.21% |
| ABCL | AbCellera Biologics Inc | 25.99 | -94.18% |
| RNXT | RenovoRx Inc | 26.04 | -94.17% |
| RXRX | Recursion Pharmaceuticals Inc - Class A | 26.45 | -94.08% |
| DARE | Dare Bioscience Inc | 26.79 | -94.00% |
| SLS | SELLAS Life Sciences Group Inc | 26.90 | -93.98% |
| ABVC | ABVC BioPharma Inc | 27.42 | -93.86% |
| ABEO | Abeona Therapeutics Inc | 27.67 | -93.81% |
| BBIO | BridgeBio Pharma Inc | 27.92 | -93.75% |
| NTLA | Intellia Therapeutics Inc | 28.12 | -93.71% |
| ARMP | Armata Pharmaceuticals Inc | 28.16 | -93.70% |
| INSM | Insmed Inc | 28.42 | -93.64% |
| RANI | Rani Therapeutics Holdings Inc Class A | 29.37 | -93.43% |
| VRDN | Viridian Therapeutics Inc | 29.68 | -93.36% |
| WHWK | Whitehawk Therapeutics Inc | 30.04 | -93.28% |
| ADAG | Adagene Inc | 31.61 | -92.93% |
| MESO | Mesoblast Ltd | 33.10 | -92.59% |
| SRZN | Surrozen Inc | 33.76 | -92.44% |
| RYTM | Rhythm Pharmaceuticals Inc | 34.39 | -92.30% |
| IMTX | Immatics N.V | 34.70 | -92.23% |
| MTNB | Matinas Biopharma Holdings Inc | 34.81 | -92.21% |
| AGIO | Agios Pharmaceuticals Inc | 35.95 | -91.95% |
| CBIO | N/A | 36.36 | -91.86% |
| TOVX | Theriva Biologics Inc | 37.16 | -91.68% |
| CBUS | Cibus Global Ltd. Class A | 39.30 | -91.20% |
| XFOR | X4 Pharmaceuticals Inc | 40.81 | -90.87% |
| OCUL | Ocular Therapeutix Inc | 40.81 | -90.87% |
| NKTR | Nektar Therapeutics | 41.48 | -90.72% |
| KTTA | Pasithea Therapeutics Corp | 42.15 | -90.57% |
| HYPD | Eyenovia Inc | 43.89 | -90.18% |
| EVMN | Evommune Inc | 44.84 | -89.96% |
| MCRB | Seres Therapeutics Inc | 45.04 | -89.92% |
| BYSI | BeyondSpring Inc | 45.99 | -89.71% |
| GLUE | Monte Rosa Therapeutics Inc | 46.04 | -89.70% |
| TRDA | Entrada Therapeutics Inc | 47.22 | -89.43% |
| PHIO | Phio Pharmaceuticals Corp | 48.01 | -89.26% |
| KRRO | Korro Bio Inc | 48.91 | -89.05% |
| SPRB | Spruce Biosciences Inc | 49.19 | -88.99% |
| CLDI | Calidi Biotherapeutics Inc | 50.83 | -88.62% |
| PPBT | Purple Biotech Ltd | 51.90 | -88.39% |
| SGMT | Sagimet Biosciences Inc - Class A | 52.50 | -88.25% |
| KZIA | Kazia Therapeutics Ltd | 53.44 | -88.04% |
| FATE | Fate Therapeutics Inc | 55.18 | -87.65% |
| CAMP | CAMP4 Therapeutics Corp | 55.57 | -87.56% |
| VYNE | VYNE Therapeutics Inc | 55.68 | -87.54% |
| PGEN | Precigen Inc | 57.77 | -87.07% |
| IBRX | ImmunityBio Inc | 57.87 | -87.05% |
| STOK | Stoke Therapeutics Inc | 58.07 | -87.00% |
| COCP | Cocrystal Pharma Inc | 58.22 | -86.97% |
| ONCY | Oncolytics Biotech Inc | 58.60 | -86.89% |
| PRTC | PureTech Health plc American Depositary Shares | 59.84 | -86.61% |
| GLMD | Galmed Pharmaceuticals Ltd | 61.38 | -86.26% |
| NBTX | Nanobiotix | 62.26 | -86.07% |
| OVID | Ovid Therapeutics Inc | 64.47 | -85.57% |
| ACIU | AC Immune SA | 65.70 | -85.30% |
| EPIX | Essa Pharma Inc | 65.79 | -85.28% |
| DMAC | DiaMedica Therapeutics Inc | 66.68 | -85.08% |
| NRIX | Nurix Therapeutics Inc | 67.32 | -84.93% |
| JANX | Janux Therapeutics Inc | 71.18 | -84.07% |
| ADXN | Addex Therapeutics Ltd | 71.50 | -84.00% |
| APRE | Aprea Therapeutics Inc | 73.15 | -83.63% |
| IVA | Inventiva | 73.66 | -83.51% |
| LEXX | Lexaria Bioscience Corp | 75.14 | -83.18% |
| SILO | SILO Pharma Inc | 76.31 | -82.92% |
| OMER | Omeros Corporation | 76.82 | -82.81% |
| MAZE | Maze Therapeutics Inc | 81.33 | -81.80% |
| NRXP | NRX Pharmaceuticals Inc | 83.25 | -81.37% |
| IMA | Ikena Oncology Inc | 83.32 | -81.35% |
| TNGX | Tango Therapeutics Inc | 86.42 | -80.66% |
| ORMP | Oramed Pharmaceuticals Inc | 86.55 | -80.63% |
| MIST | Milestone Pharmaceuticals Inc | 88.63 | -80.16% |
| OGEN | Oragenics Inc | 89.28 | -80.02% |
| ACRS | Aclaris Therapeutics Inc | 89.47 | -79.98% |
| HUMA | Humacyte Inc | 90.61 | -79.72% |
| QNTM | FSD Pharma Inc - Class B - Class B (Sub Voting) | 91.86 | -79.44% |
| CVM | Cel-Sci Corp | 92.88 | -79.21% |
| ADVM | Adverum Biotechnologies Inc | 94.37 | -78.88% |
| RAPP | Rapport Therapeutics Inc | 95.49 | -78.63% |
| AEON | AEON Biopharma Inc - Class A | 97.16 | -78.26% |
| HIND | ReShape Lifesciences Inc | 104.32 | -76.65% |
| MREO | Mereo Biopharma Group Plc | 104.68 | -76.57% |
| CYTK | Cytokinetics Inc | 105.12 | -76.47% |
| OCGN | Ocugen Inc | 108.42 | -75.74% |
| RLYB | Rallybio Corp | 109.04 | -75.60% |
| AIM | AIM ImmunoTech Inc. | 112.05 | -74.92% |
| MNOV | Medicinova Inc | 113.02 | -74.71% |
| PTGX | Protagonist Therapeutics Inc | 113.99 | -74.49% |
| SKYE | Skye Bioscience Inc | 117.90 | -73.61% |
| UPB | Upstream Bio Inc | 119.09 | -73.35% |
| GRDX | Entero Therapeutics Inc | 119.29 | -73.30% |
| ZBIO | Zenas Biopharma Inc | 119.50 | -73.26% |
| CAPR | Capricor Therapeutics Inc | 124.43 | -72.15% |
| RNAC | Cartesian Therapeutics Inc | 142.69 | -68.07% |
| OPT | Opthea Ltd | 151.40 | -66.12% |
| EYPT | EyePoint Pharmaceuticals Inc | 152.51 | -65.87% |
| DBVT | DBV Technologies | 153.33 | -65.68% |
| PRME | Prime Medicine Inc | 156.26 | -65.03% |
| MOLN | Molecular Partners AG | 156.56 | -64.96% |
| QURE | uniQure N.V. | 157.78 | -64.69% |
| NAMS | NewAmsterdam Pharma Company NV | 165.68 | -62.92% |
| CRBP | Corbus Pharmaceuticals Holdings Inc | 169.88 | -61.98% |
| CRDF | Cardiff Oncology Inc | 175.81 | -60.65% |
| KYMR | Kymera Therapeutics Inc | 182.36 | -59.19% |
| GRCE | Acasti Pharma Inc | 197.75 | -55.74% |
| LSTA | Lisata Therapeutics Inc | 200.88 | -55.04% |
| GTBP | GT Biopharma Inc | 204.96 | -54.13% |
| JUNS | Jupiter Neurosciences Inc | 212.82 | -52.37% |
| SER | AgeX Therapeutics Inc | 224.96 | -49.65% |
| ASBP | Aspire Biopharma Holdings Inc | 226.40 | -49.33% |
| TSHA | Taysha Gene Therapies Inc | 238.09 | -46.71% |
| AZTR | Azitra Inc | 239.97 | -46.29% |
| GANX | Gain Therapeutics Inc | 255.50 | -42.82% |
| CMPX | Compass Therapeutics Inc | 269.28 | -39.73% |
| ATYR | Atyr Pharma Inc | 275.73 | -38.29% |
| CYBN | Cybin Inc | 278.25 | -37.73% |
| IBIO | iBio Inc | 279.86 | -37.37% |
| YDES | YD Bio Ltd | 315.05 | -29.49% |
| CDIO | Cardio Diagnostics Holdings Inc | 319.80 | -28.43% |
| ATNM | Actinium Pharmaceuticals Inc | 320.69 | -28.23% |
| CLRB | Cellectar Biosciences Inc | 348.47 | -22.01% |
| VRNA | Verona Pharma Plc | 350.73 | -21.51% |
| AUTL | Autolus Therapeutics plc | 372.63 | -16.60% |
| ANIX | Anixa Biosciences Inc | 377.78 | -15.45% |
| RLAY | Relay Therapeutics Inc | 398.28 | -10.86% |
| TENX | Tenax Therapeutics Inc | 414.72 | -7.18% |
| CADL | Candel Therapeutics Inc | 436.42 | -2.33% |
| LXEO | Lexeo Therapeutics Inc | 478.26 | +7.04% |
| CRNX | Crinetics Pharmaceuticals Inc | 491.45 | +9.99% |
| ABOS | Acumen Pharmaceuticals Inc | 538.78 | +20.58% |
| TVRD | Cara Therapeutics Inc | 559.61 | +25.24% |
| IMRX | Immuneering Corp Class A | 563.62 | +26.14% |
| ATAI | ATAI Life Sciences N.V. | 565.76 | +26.62% |
| NGNE | Neoleukin Therapeutics Inc | 583.60 | +30.61% |
| SLN | Silence Therapeutics Plc | 588.32 | +31.67% |
| STTK | Shattuck Labs Inc | 608.39 | +36.16% |
| LNAI | Lunai Bioworks Inc | 645.16 | +44.39% |
| IMNM | Immunome Inc | 646.50 | +44.69% |
| SYRE | Spyre Therapeutics Inc | 650.22 | +45.52% |
| CNTB | Connect Biopharma Holdings Ltd | 656.66 | +46.96% |
| OTLK | Outlook Therapeutics Inc | 695.79 | +55.72% |
| OCS | Oculis Holding AG | 705.51 | +57.90% |
| XENE | Xenon Pharmaceuticals Inc | 727.44 | +62.80% |
| GRCL | Gracell Biotechnologies Inc | 732.21 | +63.87% |
| INMB | INmune Bio Inc | 760.34 | +70.17% |
| VRAX | Virax Biolabs Group Ltd - Class A | 793.06 | +77.49% |
| TNYA | Tenaya Therapeutics Inc | 813.22 | +82.00% |
| SNTI | Senti Biosciences Inc | 852.38 | +90.77% |
| COGT | Cogent Biosciences Inc | 861.15 | +92.73% |
| PROK | ProKidney Corp - Class A | 876.39 | +96.14% |
| ABSI | Absci Corp | 900.52 | +101.54% |
| PRAX | Praxis Precision Medicines Inc | 953.14 | +113.32% |
| INBX | Inhibrx Biosciences Inc | 1029.47 | +130.40% |
| CELZ | Creative Medical Technology Holdings Inc | 1195.26 | +167.50% |
| CRSP | CRISPR Therapeutics AG | 1211.19 | +171.07% |
| IBO | Impact BioMedical Inc | 1260.68 | +182.14% |
| CGON | Cg Oncology Inc | 1269.73 | +184.17% |
| ERNA | Ernexa Therapeutics Inc | 1275.37 | +185.43% |
| PCSA | Processa Pharmaceuticals Inc | 1320.06 | +195.43% |
| TTNP | Titan Pharmaceuticals Inc (de) | 1459.05 | +226.54% |
| ENTX | Entera Bio Ltd | 1547.08 | +246.24% |
| TCRT | Alaunos Therapeutics Inc | 1689.15 | +278.04% |
| INO | Inovio Pharmaceuticals Inc | 1712.37 | +283.23% |
| ATOS | Atossa Therapeutics Inc | 1872.06 | +318.97% |
| MBIO | Mustang Bio Inc | 2205.73 | +393.65% |
| ABVX | Abivax | 2425.97 | +442.94% |
| PULM | Pulmatrix Inc | 2459.21 | +450.38% |
| BCDA | BioCardia Inc | 2520.59 | +464.12% |
| BNTC | Benitec Biopharma Inc | 2770.13 | +519.96% |
| ROIV | Roivant Sciences Ltd | 3008.13 | +573.23% |
| PLRX | Pliant Therapeutics Inc | 3071.82 | +587.48% |
| CLDX | Celldex Therapeutics Inc | 3476.34 | +678.01% |
| NTHI | NeOnc Technologies Holdings Inc | 3477.63 | +678.30% |
| KYTX | Kyverna Therapeutics Inc | 3513.34 | +686.30% |
| CMRX | Chimerix Inc | 3613.35 | +708.68% |
| DNLI | Denali Therapeutics Inc | 3643.65 | +715.46% |
| SMMT | Summit Therapeutics Inc | 3891.31 | +770.89% |
| PMN | ProMIS Neurosciences Inc | 4016.22 | +798.84% |
| DNTH | Dianthus Therapeutics Inc | 4088.10 | +814.93% |
| ALXO | Alx Oncology Holdings Inc | 5085.96 | +1038.25% |
| IFRX | InflaRx N.V. | 6161.81 | +1279.03% |
| GUTS | Fractyl Health Inc | 7575.74 | +1595.47% |
| LPTX | Leap Therapeutics Inc | 8475.88 | +1796.93% |
| RLMD | Relmada Therapeutics Inc | 9001.90 | +1914.65% |
| RVMD | Revolution Medicines Inc | 9035.10 | +1922.08% |
| AVTX | Avalo Therapeutics Inc | 9875.25 | +2110.11% |
| ALT | Altimmune Inc | 10694.01 | +2293.35% |
| LYEL | Lyell Immunopharma Inc | 11272.00 | +2422.71% |
| PMCB | PharmaCyte Biotech Inc | 12904.41 | +2788.04% |
| GNLX | Genelux Corp | 16310.70 | +3550.38% |
| VTVT | vTv Therapeutics Inc - Class A | 17944.71 | +3916.08% |
| DSGN | Design Therapeutics Inc | 29402.82 | +6480.43% |
| TRML | Tourmaline Bio Inc | 30893.12 | +6813.97% |
| TIL | Instil Bio Inc | 54248.82 | +12041.04% |
| ETNB | 89bio Inc | 111568.68 | +24869.39% |
| EDSA | Edesa Biotech Inc | 130462.29 | +29097.83% |
| SVRA | Savara Inc | 145272.62 | +32412.42% |
| AKTX | Akari Therapeutics Plc | 478368.50 | +106960.23% |
| NKTX | Nkarta Inc | 1.00M | +223702.83% |